Cite
HARVARD Citation
Li, Y. et al. (2020). Pharmacokinetic Properties of Single and Multiple Doses of Ertugliflozin, a Selective Inhibitor of SGLT2, in Healthy Chinese Subjects. Clinical pharmacology in drug development. 9 (1), pp. 97-106. [Online].